# Safe Return to Regular Clinical Operation After COVID-19 Pandemic

> **NCT04377802** · NA · UNKNOWN · sponsor: **King Fahad Specialist Hospital Dammam** · enrollment: 400 (estimated)

## Conditions studied

- COVID 19

## Interventions

- **DIAGNOSTIC_TEST:** molecular testing for virus RNA using RT-PCR

## Key facts

- **NCT ID:** NCT04377802
- **Lead sponsor:** King Fahad Specialist Hospital Dammam
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-17
- **Primary completion:** 2020-11-16
- **Final completion:** 2020-12-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04377802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04377802, "Safe Return to Regular Clinical Operation After COVID-19 Pandemic". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04377802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*